BMJ  2008;336:1308-1309 (7 June), doi:10.1136/bmj.39581.495069.AD

Practice

Commentary: controversies in NICE guidance on management of type 2 diabetes

¹ Hull York Medical School, Michael White Diabetes Centre, Hull HU3 2RW, ² Hull and East Yorkshire Hospital Trust, Michael White Diabetes Centre, Hull HU3 2RW

doi: 10.1136/bmj.39560.442095.AD

The first 150 words of the full text of this article appear below.

Publication of the original guidelines (in 2002) from the National Institute for Health and Clinical Excellence (NICE) for type 2 diabetes predated the wholesale change in the delivery of diabetes services in the England and Wales. As a consequence of the national service framework in 2001 and the new general practitioners’ contract in 2003, primary care now delivers much more diabetes treatment, with fewer instances of insulin being started in secondary care. Consequently, the revised guidance¹ will now be judged much more on its relevance to general practice diabetes care, including the drive to hit targets on blood glucose control.

Initial management

It is reassuring that a trial of lifestyle intervention with education is still encouraged before a patient is started on metformin, rather than the immediate prescription of metformin at diagnosis as suggested in the consensus document from the American Diabetes Association and the European Association for the Study of Diabetes.² . . . [Full text of this article]

Targets for blood glucose control

Insulin treatment and new agents

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Management of type 2 diabetes: summary of updated NICE guidance

Philip Home, Jonathan Mant, Jose Diaz, Claire Turner on behalf of the Guideline Development Group
BMJ 2008 336: 1306-1308. [Extract] [Full Text] [PDF]

Safety of very tight blood glucose control in type 2 diabetes

Philip Home
BMJ 2008 336: 458-459. [Extract] [Full Text] [PDF]